Population pharmacokinetic and pharmacodynamic analysis to support treatment optimization of combination chemotherapy with indisulam and carboplatin

AIMS: Indisulam and carboplatin have shown synergistic activity in preclinical studies. In a dose escalation study of the combination, a treatment delay was frequently required in a 3-weekly regimen to allow recovery from myelosuppression from previous cycles. A 4-weekly regimen was better tolerated...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Zandvliet, Anthe S, Schellens, Jan H M, Dittrich, Christian, Wanders, Jantien, Beijnen, Jos H, Huitema, Alwin D R
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2008
Gaiak:
Pharmacokinetic Dynamic Relationships
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2561111/
https://ncbi.nlm.nih.gov/pubmed/18637887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2008.03230.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak